Onconetix, Inc. Quarterly Operating Income (Loss) in USD from Q1 2021 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Onconetix, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q1 2024.
  • Onconetix, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$11.1M, a 289% decline year-over-year.
  • Onconetix, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$44.3M, a 210% decline year-over-year.
  • Onconetix, Inc. annual Operating Income (Loss) for 2023 was -$36M, a 167% decline from 2022.
  • Onconetix, Inc. annual Operating Income (Loss) for 2022 was -$13.5M, a 294% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$44.3M -$11.1M -$8.23M -289% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
Q4 2023 -$36M -$22M -$18.8M -579% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-11
Q3 2023 -$17.2M -$4.49M -$618K -16% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-17
Q2 2023 -$16.6M -$6.65M -$2.35M -54.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-10-20
Q1 2023 -$14.3M -$2.85M -$778K -37.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-20
Q4 2022 -$13.5M -$3.25M -$2.04M -170% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-11
Q3 2022 -$11.4M -$3.87M -$2.77M -253% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 -$8.66M -$4.29M -$3.5M -442% Apr 1, 2022 Jun 30, 2022 10-Q 2023-10-20
Q1 2022 -$5.16M -$2.07M -$1.74M -536% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$3.42M -$1.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$1.1M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$792K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$326K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.